- The physician ASC ownership playbook
- Oracle Health, 8 health systems must face data breach lawsuit
- Mount Sinai to centralize oversight of its growing AI portfolio
- Duke Health, Texas Health Resources partner with clinical AI company
- Kenya halts US-backed Ebola facility after contempt of court ruling
- Oregon system cuts 45 leadership roles
- Oncology’s ‘last-mile problem’: NCI care bypasses patients who need it most
- Judy Faulkner on AI replacing physicians: ‘I don’t know that I agree’
- ‘Surgical portfolio moves’: Inside the new era of health plan M&A
- Bronson hospital COO exits; interim named
- Fugitive in $3.7B Medicare fraud scheme returned to US after capture
- A new patient safety threat emerging in anesthesia
- $6.5B in false claims, 90 physicians charged in DOJ’s massive healthcare fraud sweep
- Mercy expands pediatric endoscopy, adds sedation-free procedures
- Rock Dental Brands marks record growth during first half of 2026: 4 notes
- The training pipeline that funnels physicians into hospital employment
- Connecticut woman accused of stealing $78K from dental office
- The real physician paycheck: Salary vs. total compensation
- Dental website operator settles class-action privacy lawsuit for $12.7M
- Align Technology appoints new board chair
- The $2.8B problem with CMS’ new joint replacement model
- 1 year since HR 1: How the federal bill is upending oral healthcare
- What’s pushing physicians out of practice 9 years early?
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Psychologists sound alarm on patients using AI for mental health: 5 notes
- American Association for Thoracic Surgery taps new president
- Indiana mental health center expands service area
- Racial gaps persist in mental healthcare for young adults with suicidal thoughts
- Physicians open ophthalmic ASC in Minnesota
- UT Southwestern opens psychiatric hospital
- Hackensack Meridian to upgrade pediatric behavioral health tech
- Oregon State Hospital back in compliance after 2 years
- New Orleans East Hospital breaks ground on 1st inpatient behavioral health unit
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
- Michigan hospitals denounce legislation to cap prices, limit mergers
- Incyte drops lawsuit as CMS relents on classification of Opzelura
- Medicare’s AI push snarls patients and doctors in errors and delays
- Midlife Strength Training Linked to Lower Diabetes Risk
- Cadence secures $100M series C to advance AI-powered care for chronic disease
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Hallmark Health Care Solutions launches AI solution to tackle workforce ‘black box’
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- Illinois passes bill regulating dental reimbursement practices
- The shifting dental care landscape
- Harvard to end faculty dental practice, transfer clinic to private owner due to financial constraints
- MCNA Dental agrees to multimillion-dollar settlement over 2023 ransomware attack
- Former Iowa dental office employee accused of using patient financial information for personal purchases
- Optum Behavioral Health names chief medical officer
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Half of U.S. adults can't afford healthcare, Gallup poll finds
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- Real-world data powers next-gen biopharma
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- Rural, independent Kansas hospitals launch clinically integrated network
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
Healthcare freedom aficionados remember Jay Bhattacharya as co-author of The Great Barrington Declaration.
The New York Post interviews him after his First Amendment case again reached an appropriate decision. The article is supported by multiple photos and videos at the publisher's link.
https://nypost.com/2023/09/20/how-dr-jay-bhattacharya-beat-biden-administration-censorship/
The Biden administration tried to censor this Stanford doctor, but he won in court
Dr. Jay Bhattacharya: We 'failed' as a nation during COVID and experts are to blameA federal court of appeals ruled earlier this month that the White House, surgeon general, CDC and FBI “likely violated the First Amendment” by exerting a pressure campaign on social media companies to censor COVID-19 skeptics — including Stanford epidemiologist Dr. Jay Bhattacharya.
“I think this ruling is akin to the second Enlightenment,” Bhattacharya told The Post. “It’s a ruling that says there’s a democracy of ideas. The issue is not whether the ideas are wrong or right. The question is who gets to control what ideas are expressed in the public square?”
The court ordered that the Biden administration and other federal agencies “shall take no actions, formal or informal, directly or indirectly” to coerce social media companies “to remove, delete, suppress or reduce” free speech.
Bhattacharya, a professor of medicine, economics and health research policy at Stanford University, co-authored the Great Barrington Declaration in the fall of 2020 with professors from Harvard and Oxford.
The epidemiologists advocated for “focused protection” — safeguarding the most vulnerable Americans while cautiously allowing others to function as normally as possible — rather than broad pandemic lockdowns.
“We were just acting as scientists, but almost immediately we were censored,” said Bhattacharya, director of Stanford’s Center for Demography and Economics of Health and Aging. “Google de-boosted us. Our Facebook page was removed. It was just a crazy time.
“The kinds of things that the federal government was telling social media companies to censor included us — along with millions of other posts from countless other people who were criticizing government COVID policy,” he added.
A New Orleans-based three-judge panel found that the federal government “likely coerced or significantly encouraged social-media platforms to moderate content” by vaguely threatening adverse regulatory consequences if social media companies did not suppress certain viewpoints on the pandemic.
“The government had a vast censorship enterprise,” Bhattacharya said. “It was systematically used to threaten and coerce and jawbone and tell all these social media companies, ‘You better listen to us: Censor these people, censor these ideas, or else.’”
It was later revealed that then-NIH director Dr. Francis Collins called for a “swift and devastating takedown” of Bhattacharya and his co-authors — whom Collins dubbed “fringe epidemiologists” —in an email to Dr. Anthony Fauci.
Subsequent reporting from Elon Musk’s so-called Twitter Files — internal documents and communications released by Musk, after he bought the platform, to expose Twitter’s inner workings — revealed that Bhattachrya’s profile was being suppressed on the platform.
“It’s akin to the efforts by governments to suppress the printing press when it first was invented, when books represented an enormous threat to power,” Bhattacharya said, referring to efforts by King Henry VIII and the Catholic Church to curb use of the printing press in the 16th century.
“There’s an analogous fight that’s currently going on with social media, which makes it vastly easier for anybody to express their ideas, and very powerful people find that incredibly threatening.”
The September 8 ruling affirmed but narrowed a lower court order, issued on July 4 by US District Judge Terry Doughty, which found that the Biden administration and other federal agencies “engaged in a years-long pressure campaign [on social media outlets] designed to ensure that the censorship aligned with the government’s preferred viewpoints” and that “the platforms, in capitulation to state-sponsored pressure, changed their moderation policies.”
Bhattacharya says the first victory, although in a lower court, was the most exciting to him.
“I was just absolutely thrilled, especially to have it on July 4th,” he said. “I think that judge was sending a message by issuing this ruling on July 4th that we’re going to restore free speech in this country.”
The Biden administration appealed to the Supreme Court on Thursday — a move that Bhattacharya anticipated.
But he believes it’s “unlikely” the Supreme Court will overturn the Fifth Circuit’s decision.
He feels his is a landmark case in curbing the influence the government has over social media — on matters that extend far beyond just COVID-19 and lockdowns.
“This new technology has created enormous opportunities for people to participate in debate in the public square,” Bhattacharya said. “And I hope that this is the beginning of a legal infrastructure that enables that to happen — rather than the opposite, which is a dark age where the government gets to decide what’s true and what’s allowed to be said.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















